Company

Syntax Bio

Biotechnology Research Chicago, Illinois, United States 13 employees

Employees: 13
Contacts: 2
Emails: 2
Phones: 2

www.syntax-bio.com LinkedIn

Syntax Bio Overview

Headquarters: Chicago, Illinois, United States
Website: www.syntax-bio.com
Industry: Biotechnology Research
Employees: 13
Founded: 2021
Funding: 15
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Over four years at Atara Biotherapeutics

About Syntax Bio

Syntax Bio's regenerative medicine discovery platform overcomes the longstanding challenges in stem cell derived therapies by directly controlling and accelerating cell differentiation. A shorter and more reliable iPSC differentiation process improves patient access by making stem cell discovery and manufacturing faster, less costly and scalable. Synatx’s proprietary Cellgorithm technology mimics human development using a sequential synthetic biology CRISPR based system to generate a wide diversity of functional cell types to enable new cell and gene therapy product opportunities.

Syntax Bio Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

Syntax Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
John Craighead, Ph.d.	Strategic Biotech CEO - Capital Markets - Corporate Development - Investor Relations - M&a - Culture & Team Building	San Francisco Bay Area, United States	Email Phone
Matthew Macdougall, Md Phd	Allergy and Immunology Fellow and Biotech Co-founder/scientific Advisor		View
Nick Timmins	Executive Leader in Advanced Therapies		View
Renee De Pooter	Senior Scientist at Syntax-bio	Greater Chicago Area, United States	Email Phone